VIA
EXEL icon

Vident Investment Advisory’s Exelixis EXEL Stock Holding History

Vident Investment Advisory’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,124
Closed -$313K – 1233
2023
Q1 		$313K Buy
16,124
+2,651
+20% +$46.2K 0.01% 938
2022
Q4 		$216K Sell
13,473
-102,974
-88% -$1.68M 0.01% 1012
2022
Q3 		$1.77M Buy
+116,447
New +$2.25M 0.06% 408
2020
Q3 		– Sell
-13,890
Closed -$330K – 897
2020
Q2 		$330K Buy
+13,890
New +$322K 0.02% 753
2019
Q2 		– Sell
-15,565
Closed -$370K – 513
2019
Q1 		$370K Sell
15,565
-7,874
-34% -$180K 0.02% 649
2018
Q4 		$461K Sell
23,439
-1,518
-6% -$27.1K 0.03% 606
2018
Q3 		$442K Sell
24,957
-506
-2% -$9.87K 0.02% 738
2018
Q2 		$548K Buy
25,463
+6,030
+31% +$125K 0.02% 619
2018
Q1 		$396K Sell
19,433
-3,851
-17% -$106K 0.02% 713
2017
Q4 		$708K Sell
23,284
-9,032
-28% -$240K 0.03% 451
2017
Q3 		$783K Buy
+32,316
New +$860K 0.04% 401

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vident Investment Advisory's EXEL Position: Q2 2023 in Review

Vident Investment Advisory sold out of Exelixis (EXEL) in Q2 2023, closing a stake of 16,124 shares — an estimated $313K sold.

Vident Investment Advisory first reported a position in EXEL in Q3 2017 and held it in 11 quarters. The position peaked at $1.77M in Q3 2022. 378 funds tracked by Wall St. Rank hold EXEL as of Q2 2023.

  • Vident Investment Advisory reported no remaining Exelixis position as of Q2 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 16,124 Exelixis shares in Q2 2023, an estimated $313K.
  • Vident Investment Advisory first reported a position in Exelixis in Q3 2017 and held it in 11 quarters.
  • Vident Investment Advisory's Exelixis position peaked at $1.77M in Q3 2022.
  • 378 funds tracked by Wall St. Rank held Exelixis as of Q2 2023.

Based on Vident Investment Advisory's 13F filing for Q2 2023, filed 11 Aug 2023.